NCT05400265 2024-02-06
Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor
Shanghai Henlius Biotech
Phase 1 Completed
Shanghai Henlius Biotech
Tracon Pharmaceuticals Inc.